KEQU

+ Watchlist + Portfolio

Kewaunee Scientific Corp.

Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $33.98
52-Week Range: $32.00 – $46.57
Market Cap: $98.91M
P/E (TTM): 12.38
EPS (TTM): 2.76
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.32
PEG Ratio: —
Return on Equity: 12.53%
Return on Assets: 5.10%
Gross Margin: 28.55%
Operating Margin: 4.76%
Profit Margin: 2.97%
Current Ratio: 2.20
Debt/Equity: 0.72
Total Debt: $55.47M
Free Cash Flow: $9.24M
Revenue Growth: -6.70%
Earnings Growth: -44.20%
Enterprise Value: $148.35M

KEQU Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$219.49M	$203.75M	$240.47M	$282.00M
Cost of Revenue	$183.91M	$151.70M	$171.62M	$201.56M
Gross Profit	$35.59M	$52.05M	$68.86M	$80.44M
Selling, General & Admin	$71.00K	$4.18M	—	—
Operating Expenses	$30.22M	$33.77M	$51.10M	$63.73M
Operating Income	$5.36M	$18.28M	$17.76M	$16.71M
EBITDA	$9.10M	$18.04M	$22.76M	$23.88M
Pretax Income	$4.50M	$13.12M	$14.79M	$13.73M
Income Tax	$3.14M	-$5.94M	$3.20M	$3.27M
Net Income	$738.00K	$18.75M	$11.40M	$9.62M
Diluted EPS	0.25	6.38	3.83	3.22
Diluted Shares	2.90M	2.94M	2.98M	2.98M

KEQU Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$8.08M	$23.27M	$14.94M	$9.95M
Receivables	$46.08M	$45.06M	$62.38M	$58.74M
Inventory	$21.89M	$20.68M	$32.85M	$30.53M
Current Assets	$87.92M	$96.82M	$118.36M	$105.40M
Total Assets	$118.90M	$134.77M	$194.65M	$178.31M
Current Liabilities	$40.05M	$40.78M	$53.71M	$48.35M
Long-Term Debt	—	—	$33.95M	$14.80M
Total Debt	$12.92M	$11.00M	$50.16M	$30.18M
Total Liabilities	$80.41M	$78.56M	$128.41M	$101.50M
Retained Earnings	$28.76M	$47.51M	$58.92M	$68.54M
Shareholders' Equity	$37.41M	$54.76M	$64.46M	$74.72M
Working Capital	$47.87M	$56.04M	$64.65M	$57.05M
Net Debt	—	—	$22.90M	$9.82M

KEQU Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$3.79M	$19.56M	$14.78M	$18.63M
Capital Expenditure	-$4.15M	-$4.37M	-$2.17M	-$3.94M
Free Cash Flow	-$7.94M	$15.19M	$12.62M	$14.70M
Depreciation & Amortisation	$2.87M	$3.13M	$4.76M	$6.28M
Stock-Based Compensation	$886.00K	$1.03M	$1.44M	$2.13M
Investing Cash Flow	-$4.15M	-$4.37M	-$30.90M	-$3.94M
Financing Cash Flow	$14.93M	-$3.01M	$7.41M	-$19.33M
Share Repurchases	$0.00	-$2.00M	-$1.60M	$0.00
Net Change in Cash	$6.99M	$12.18M	-$8.71M	-$4.63M

KEQU Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Revenue	$77.15M	$71.10M	$70.10M	$69.40M	$71.40M	$66.32M
Cost of Revenue	$53.11M	$50.17M	$50.38M	$50.85M	$50.16M	$46.68M
Gross Profit	$24.04M	$20.93M	$19.72M	$18.55M	$21.25M	$19.64M
Operating Expenses	$15.54M	$16.12M	$15.61M	$15.96M	$16.03M	$16.48M
Operating Income	$8.50M	$4.81M	$4.11M	$2.58M	$5.22M	$3.16M
EBITDA	$9.89M	$6.53M	$6.09M	$4.31M	$6.94M	$4.78M
Pretax Income	$7.15M	$3.92M	$3.45M	$1.60M	$4.76M	$2.56M
Income Tax	$2.20M	$761.00K	$915.00K	$528.00K	$1.06M	$717.00K
Net Income	$4.85M	$3.09M	$2.44M	$692.00K	$3.39M	$1.71M
Diluted EPS	1.63	1.04	0.82	0.23	1.13	0.58
Diluted Shares	2.98M	2.96M	2.99M	2.98M	3.00M	2.92M

KEQU Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Cash & Equivalents	$14.94M	$19.49M	$12.59M	$8.15M	$9.95M	$8.25M
Receivables	$62.38M	$56.90M	$59.02M	$54.13M	$58.74M	$58.20M
Inventory	$32.85M	$34.92M	$35.50M	$32.91M	$30.53M	$29.79M
Current Assets	$118.36M	$117.15M	$113.64M	$103.58M	$105.40M	$103.95M
Total Assets	$194.65M	$193.49M	$189.07M	$175.96M	$178.31M	$175.80M
Current Liabilities	$53.71M	$50.49M	$45.81M	$48.78M	$48.35M	$47.23M
Long-Term Debt	$33.95M	$33.71M	$31.64M	$16.03M	$14.80M	$13.58M
Total Debt	$50.16M	$48.48M	$46.70M	$32.51M	$30.18M	$29.05M
Total Liabilities	$128.41M	$124.62M	$117.36M	$103.43M	$101.50M	$98.58M
Retained Earnings	$58.92M	$62.01M	$64.46M	$65.15M	$68.54M	$70.24M
Shareholders' Equity	$64.46M	$67.08M	$69.85M	$70.67M	$74.72M	$75.00M
Working Capital	$64.65M	$66.66M	$67.83M	$54.79M	$57.05M	$56.72M
Net Debt	$22.90M	$17.62M	$23.07M	$14.31M	$9.82M	$10.86M

KEQU Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Operating Cash Flow	$9.41M	$5.79M	-$4.26M	$11.65M	$5.46M	$1.98M
Capital Expenditure	-$516.00K	-$771.00K	-$1.57M	-$668.00K	-$928.00K	-$772.00K
Free Cash Flow	$8.89M	$5.02M	-$5.83M	$10.98M	$4.53M	$1.20M
Depreciation & Amortisation	$1.57M	$1.55M	$1.58M	$1.60M	$1.55M	$1.59M
Stock-Based Compensation	$370.00K	$521.00K	$561.00K	$542.00K	$502.00K	$1.90M
Investing Cash Flow	-$516.00K	-$771.00K	-$1.57M	-$668.00K	-$928.00K	-$772.00K
Financing Cash Flow	-$4.34M	-$1.46M	-$853.00K	-$14.06M	-$2.95M	-$2.50M
Share Repurchases	-$1.60M	$0.00	—	—	—	-$529.00K
Net Change in Cash	$4.55M	$3.56M	-$6.69M	-$3.08M	$1.58M	-$1.29M

Market Snapshot

About

Kewaunee Scientific Corp. designs, manufactures, and installs laboratory and technical furniture for research, healthcare, and educational facilities. The company's products include fume hoods, casework, workstations, and other specialized equipment used in science labs. Kewaunee serves pharmaceutical, biotechnology, university, and government laboratory markets. The company operates manufacturing facilities in North America and internationally.